Dupont Capital Management Corp Kura Oncology, Inc. Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023
SELL
$11.23 - $16.9 $12,330 - $18,556
-1,098 Reduced 9.68%
10,243 $0
Q3 2022

Oct 31, 2022
SELL
$12.01 - $19.45 $53,348 - $86,396
-4,442 Reduced 28.14%
11,341 $155,000
Q1 2022

Apr 27, 2022
SELL
$11.78 - $16.98 $16,444 - $23,704
-1,396 Reduced 8.13%
15,783 $254,000
Q4 2021

Jan 31, 2022
BUY
$12.22 - $19.57 $209,927 - $336,193
17,179 New
17,179 $241,000

Others Institutions Holding KURA

# of Institutions
185
Shares Held
81.8M
Call Options Held
42.1K
Put Options Held
34K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email